Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First in Human Phase I Randomized and Controlled Trial to Test Safety and Immunogenicity of a Multivalent Vaccine Against Neisseria Gonorrhoeae

NCT07758972 is registered in ClinicalTrials.gov with LimmaTech Biologics AG as lead sponsor.

NCT NCT07758972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07758972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First in Human Phase I Randomized and Controlled Trial to Test Safety and Immunogenicity of a Multivalent Vaccine Against Neisseria Gonorrhoeae
Lead sponsor
LimmaTech Biologics AG
Phase
Phase 1
Overall status
Recruiting
Start date
August 19, 2026
Completion date
September 23, 2027
Enrollment
142 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neisseria gonorrhea